ID   GNAS2_RAT               Reviewed;         394 AA.
AC   P63095; P04894; P08755; Q05087; Q45QM7; Q9Z1R8;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   02-OCT-2024, entry version 156.
DE   RecName: Full=Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;
DE            EC=3.6.5.- {ECO:0000250|UniProtKB:P63092};
DE   AltName: Full=Adenylate cyclase-stimulating G alpha protein;
DE   AltName: Full=G-alpha-8;
GN   Name=Gnas; Synonyms=Gnas1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GNAS-1).
RX   PubMed=3086867; DOI=10.1073/pnas.83.11.3776;
RA   Itoh H., Kozasa T., Nagata S., Nakamura S., Katada T., Ui M., Iwai S.,
RA   Ohtsuka E., Kawasaki H., Suzuki K., Kaziro Y.;
RT   "Molecular cloning and sequence determination of cDNAs for alpha subunits
RT   of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:3776-3780(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GNAS-1).
RX   PubMed=2820999; DOI=10.1016/s0021-9258(18)47929-x;
RA   Jones D.T., Reed R.R.;
RT   "Molecular cloning of five GTP-binding protein cDNA species from rat
RT   olfactory neuroepithelium.";
RL   J. Biol. Chem. 262:14241-14249(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GNAS-3), AND TISSUE SPECIFICITY.
RC   TISSUE=Thyroid;
RX   PubMed=8486667; DOI=10.1016/s0021-9258(18)98427-9;
RA   Crawford J.A., Mutchler K.J., Sullivan B.E., Lanigan T.M., Clark M.S.,
RA   Russo A.F.;
RT   "Neural expression of a novel alternatively spliced and polyadenylated Gsa
RT   alpha transcript.";
RL   J. Biol. Chem. 268:9879-9885(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GNAS-2).
RC   STRAIN=New England Deaconess Hospital;
RA   Wang Y.Z., Kehlenbach R.H., Huttner W.B.;
RT   "Molecular characterization of XL2, a neuroendocrine-specific luminal
RT   Golgi-resident protein.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GNAS-1).
RC   STRAIN=SHR, and Wistar Kyoto;
RA   Jackson E.K., Zhu C.;
RT   "Genetic similarity between spontaneously hypertensive rats and Wistar-
RT   Kyoto rats in the coding regions of signal transduction proteins.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GNAS-1).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [8]
RP   STRUCTURE BY NMR OF 81-209.
RX   PubMed=7500342; DOI=10.1006/jmbi.1995.0647;
RA   Benjamin D.R., Markby D.W., Bourne H.R., Kuntz I.D.;
RT   "Solution structure of the GTPase activating domain of alpha s.";
RL   J. Mol. Biol. 254:681-691(1995).
RN   [9]
RP   PALMITOYLATION AT CYS-3, AND MUTAGENESIS OF CYS-3.
RX   PubMed=8347607; DOI=10.1021/bi00083a001;
RA   Degtyarev M.Y., Spiegel A.M., Jones T.L.Z.;
RT   "The G protein alpha s subunit incorporates [3H]palmitic acid and mutation
RT   of cysteine-3 prevents this modification.";
RL   Biochemistry 32:8057-8061(1993).
RN   [10] {ECO:0007744|PDB:8UHB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.35 ANGSTROMS) IN COMPLEX WITH TAAR1;
RP   GNB1 AND GNG2, AND SUBUNIT.
RX   PubMed=38168118; DOI=10.1038/s41467-023-44601-4;
RA   Zilberg G., Parpounas A.K., Warren A.L., Yang S., Wacker D.;
RT   "Molecular basis of human trace amine-associated receptor 1 activation.";
RL   Nat. Commun. 15:108-108(2024).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins) function as
CC       transducers in numerous signaling pathways controlled by G protein-
CC       coupled receptors (GPCRs). The alpha chain contains the guanine
CC       nucleotide binding site and alternates between an active, GTP-bound
CC       state and an inactive, GDP-bound state. Signaling by an activated GPCR
CC       promotes GDP release and GTP binding. The alpha subunit has a low
CC       GTPase activity that converts bound GTP to GDP, thereby terminating the
CC       signal. Both GDP release and GTP hydrolysis are modulated by numerous
CC       regulatory proteins. Signaling involves the activation of adenylyl
CC       cyclases, resulting in increased levels of the signaling molecule cAMP.
CC       Functions downstream of beta-adrenergic receptors. Stimulates the Ras
CC       signaling pathway via RAPGEF2. {ECO:0000250|UniProtKB:P63092}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:P63092};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670;
CC         Evidence={ECO:0000250|UniProtKB:P63092};
CC   -!- SUBUNIT: Heterotrimeric G proteins are composed of 3 units; alpha, beta
CC       and gamma (PubMed:38168118). The alpha chain contains the guanine
CC       nucleotide binding site (By similarity). Interacts with CRY1; the
CC       interaction may block GPCR-mediated regulation of cAMP concentrations.
CC       Interacts with ADCY6 and stimulates its adenylyl cyclase activity (By
CC       similarity). Interacts with ADCY2 and ADCY5 (By similarity). Stimulates
CC       the ADCY5 adenylyl cyclase activity (By similarity). Interaction with
CC       SASH1 (By similarity). Interacts with GASL2L2 (By similarity).
CC       {ECO:0000250|UniProtKB:P04896, ECO:0000250|UniProtKB:P63092,
CC       ECO:0000269|PubMed:38168118}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P63094};
CC       Lipid-anchor {ECO:0000250|UniProtKB:P63094}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=Gnas-1;
CC         IsoId=P63095-1; Sequence=Displayed;
CC       Name=Gnas-2;
CC         IsoId=P63095-2; Sequence=VSP_021154;
CC       Name=Gnas-3; Synonyms=GsaN1;
CC         IsoId=P63095-3; Sequence=VSP_021155, VSP_021156;
CC       Name=XLas-1;
CC         IsoId=Q63803-1; Sequence=External;
CC       Name=Nesp55;
CC         IsoId=Q792G6-1; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Isoform Gnas-3 is abundant in brain with
CC       intermediate levels in skeletal muscle and very low levels in other
CC       tissues. {ECO:0000269|PubMed:8486667}.
CC   -!- MISCELLANEOUS: This protein is produced by a bicistronic gene which
CC       also produces the ALEX protein from an overlapping reading frame.
CC   -!- MISCELLANEOUS: The GNAS locus is imprinted in a complex manner, giving
CC       rise to distinct paternally, maternally and biallelically expressed
CC       proteins. The XLas isoforms are paternally derived, the Gnas isoforms
CC       are biallelically derived and the Nesp55 isoforms are maternally
CC       derived.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(s) subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M12673; AAA41261.1; -; mRNA.
DR   EMBL; M17525; AAA40827.1; -; mRNA.
DR   EMBL; L10326; AAA41664.1; -; mRNA.
DR   EMBL; AF107844; AAD11802.1; -; mRNA.
DR   EMBL; DQ120475; AAZ23814.1; -; mRNA.
DR   EMBL; DQ120476; AAZ23815.1; -; mRNA.
DR   EMBL; BC061967; AAH61967.1; -; mRNA.
DR   PIR; A27423; RGRTA2.
DR   PIR; A46685; A46685.
DR   RefSeq; NP_062005.1; NM_019132.1. [P63095-1]
DR   PDB; 8UHB; EM; 3.35 A; C=1-394.
DR   PDBsum; 8UHB; -.
DR   AlphaFoldDB; P63095; -.
DR   EMDB; EMD-42268; -.
DR   SMR; P63095; -.
DR   BioGRID; 247005; 8.
DR   IntAct; P63095; 2.
DR   MINT; P63095; -.
DR   iPTMnet; P63095; -.
DR   PhosphoSitePlus; P63095; -.
DR   SwissPalm; P63095; -.
DR   jPOST; P63095; -.
DR   Ensembl; ENSRNOT00000111199.1; ENSRNOP00000080642.1; ENSRNOG00000047374.3. [P63095-1]
DR   Ensembl; ENSRNOT00055001712; ENSRNOP00055001345; ENSRNOG00055001007. [P63095-1]
DR   Ensembl; ENSRNOT00060001672; ENSRNOP00060000890; ENSRNOG00060001165. [P63095-1]
DR   Ensembl; ENSRNOT00065021748; ENSRNOP00065016847; ENSRNOG00065013234. [P63095-1]
DR   GeneID; 24896; -.
DR   AGR; RGD:2716; -.
DR   CTD; 2778; -.
DR   RGD; 2716; Gnas.
DR   GeneTree; ENSGT00940000156300; -.
DR   OMA; DHVAKCW; -.
DR   OrthoDB; 2897309at2759; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   GO; GO:0030142; C:COPI-coated Golgi to ER transport vesicle; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0055037; C:recycling endosome; IDA:RGD.
DR   GO; GO:0001726; C:ruffle; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0032588; C:trans-Golgi network membrane; ISO:RGD.
DR   GO; GO:0010856; F:adenylate cyclase activator activity; ISS:UniProtKB.
DR   GO; GO:0010854; F:adenylate cyclase regulator activity; ISO:RGD.
DR   GO; GO:0047391; F:alkylglycerophosphoethanolamine phosphodiesterase activity; IDA:MGI.
DR   GO; GO:0043014; F:alpha-tubulin binding; IDA:RGD.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; IPI:RGD.
DR   GO; GO:0051430; F:corticotropin-releasing hormone receptor 1 binding; IPI:RGD.
DR   GO; GO:0031748; F:D1 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0003925; F:G protein activity; ISO:RGD.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:RGD.
DR   GO; GO:0031681; F:G-protein beta-subunit binding; IDA:RGD.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IDA:RGD.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; IPI:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031852; F:mu-type opioid receptor binding; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0060348; P:bone development; ISO:RGD.
DR   GO; GO:0051216; P:cartilage development; ISO:RGD.
DR   GO; GO:0071870; P:cellular response to catecholamine stimulus; IDA:BHF-UCL.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; ISO:RGD.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IDA:BHF-UCL.
DR   GO; GO:0050890; P:cognition; ISO:RGD.
DR   GO; GO:0048589; P:developmental growth; ISO:RGD.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; ISO:RGD.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; ISO:RGD.
DR   GO; GO:0001958; P:endochondral ossification; ISO:RGD.
DR   GO; GO:0006112; P:energy reserve metabolic process; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0071514; P:genomic imprinting; ISO:RGD.
DR   GO; GO:0060789; P:hair follicle placode formation; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IMP:RGD.
DR   GO; GO:0040015; P:negative regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IMP:RGD.
DR   GO; GO:0040032; P:post-embryonic body morphogenesis; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:2000828; P:regulation of parathyroid hormone secretion; ISO:RGD.
DR   GO; GO:0009966; P:regulation of signal transduction; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0071107; P:response to parathyroid hormone; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0007606; P:sensory perception of chemical stimulus; IBA:GO_Central.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.
DR   CDD; cd00066; G-alpha; 1.
DR   Gene3D; 1.10.400.10; GI Alpha 1, domain 2-like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR000367; Gprotein_alpha_S.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; GTP-BINDING PROTEIN ALPHA SUBUNIT; 1.
DR   PANTHER; PTHR10218:SF365; GUANINE NUCLEOTIDE-BINDING PROTEIN G(S) SUBUNIT ALPHA XL; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00443; GPROTEINAS.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF47895; Transducin (alpha subunit), insertion domain; 1.
DR   PROSITE; PS51882; G_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; GTP-binding; Hydrolase;
KW   Isopeptide bond; Lipoprotein; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Palmitate; Phosphoprotein; Reference proteome;
KW   Transducer; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   CHAIN           2..394
FT                   /note="Guanine nucleotide-binding protein G(s) subunit
FT                   alpha isoforms short"
FT                   /id="PRO_0000203725"
FT   DOMAIN          39..394
FT                   /note="G-alpha"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          42..55
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          68..90
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          196..204
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          219..228
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          288..295
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          364..369
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   COMPBIAS        9..23
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         47..55
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   BINDING         54
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   BINDING         197..204
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   BINDING         204
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   BINDING         223..227
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   BINDING         292..295
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   BINDING         366
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   LIPID           2
FT                   /note="N-palmitoyl glycine"
FT                   /evidence="ECO:0000250|UniProtKB:P04896"
FT   LIPID           3
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:8347607"
FT   CROSSLNK        300
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P63092"
FT   VAR_SEQ         1..46
FT                   /note="MGCLGNSKTEDQRNEEKAQREANKKIEKQLQKDKQVYRATHRLLLL -> MG
FT                   DSVQILLVFMDK (in isoform Gnas-2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_021154"
FT   VAR_SEQ         87..91
FT                   /note="EKATK -> VYYPH (in isoform Gnas-3)"
FT                   /evidence="ECO:0000303|PubMed:8486667"
FT                   /id="VSP_021155"
FT   VAR_SEQ         92..394
FT                   /note="Missing (in isoform Gnas-3)"
FT                   /evidence="ECO:0000303|PubMed:8486667"
FT                   /id="VSP_021156"
FT   MUTAGEN         3
FT                   /note="C->A: Abolishes S-palmitoylation."
FT                   /evidence="ECO:0000269|PubMed:8347607"
FT   HELIX           11..37
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          49..55
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   HELIX           56..59
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          217..219
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   TURN            232..234
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          239..242
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          246..249
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          265..269
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   HELIX           270..278
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          280..284
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          287..292
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   HELIX           294..302
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   TURN            308..310
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   TURN            332..334
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   HELIX           335..352
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   STRAND          359..362
FT                   /evidence="ECO:0007829|PDB:8UHB"
FT   HELIX           372..390
FT                   /evidence="ECO:0007829|PDB:8UHB"
SQ   SEQUENCE   394 AA;  45664 MW;  20341187BE4412ED CRC64;
     MGCLGNSKTE DQRNEEKAQR EANKKIEKQL QKDKQVYRAT HRLLLLGAGE SGKSTIVKQM
     RILHVNGFNG EGGEEDPQAA RSNSDGEKAT KVQDIKNNLK EAIETIVAAM SNLVPPVELA
     NPENQFRVDY ILSVMNVPNF DFPPEFYEHA KALWEDEGVR ACYERSNEYQ LIDCAQYFLD
     KIDVIKQADY VPSDQDLLRC RVLTSGIFET KFQVDKVNFH MFDVGGQRDE RRKWIQCFND
     VTAIIFVVAS SSYNMVIRED NQTNRLQEAL NLFKSIWNNR WLRTISVILF LNKQDLLAEK
     VLAGKSKIED YFPEFARYTT PEDATPEPGE DPRVTRAKYF IRDEFLRIST ASGDGRHYCY
     PHFTCAVDTE NIRRVFNDCR DIIQRMHLRQ YELL
//
